Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 990  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
Read this article


    Article Cited by others


Low-dose inhaled versus standard dose oral form of anti-tubercular drugs: Concentrations in bronchial epithelial lining fluid, alveolar macrophage and serum

Katiyar S K, Bihari S, Prakash S

Year : 2008| Volume: 54| Issue : 3 | Page no: 245-246

   This article has been cited by
1 Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis
Yong-Soon Cho, Tae Won Jang, Hyo-Jung Kim, Jee Youn Oh, Hyun-Kyung Lee, Hye Kyeong Park, Jong-Lyul Ghim, Nguyen Phuoc Long, Yumi Park, Young-Kyung Choi, Nguyen Thi Thu Phuong, Jae-Gook Shin
The Journal of Clinical Pharmacology. 2021; 61(12): 1567
[Pubmed]  [Google Scholar] [DOI]
2 Nanoparticle-mediated macrophage targeting—a new inhalation therapy tackling tuberculosis
Shaimaa Makled, Nabila Boraie, Noha Nafee
Drug Delivery and Translational Research. 2021; 11(3): 1037
[Pubmed]  [Google Scholar] [DOI]
3 Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection
Matteo Puccetti, Larissa Gomes dos Reis, Marilena Pariano, Claudio Costantini, Giorgia Renga, Maurizio Ricci, Daniela Traini, Stefano Giovagnoli
International Journal of Pharmaceutics. 2021; 607: 121004
[Pubmed]  [Google Scholar] [DOI]
4 Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis
Renata Ribeiro de Castro, Valério Todaro, Luiz Claudio Rodrigues Pereira da Silva, Alice Simon, Flavia Almada do Carmo, Valeria Pereira de Sousa, Carlos Rangel Rodrigues, Bruno Sarmento, Anne Marie Healy, Lucio Mendes Cabral
Journal of Drug Delivery Science and Technology. 2020; 58: 101805
[Pubmed]  [Google Scholar] [DOI]
5 In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?
Eleonora Truzzi, Thais Leite Nascimento, Valentina Iannuccelli, Luca Costantino, Eliana Martins Lima, Eliana Leo, Cristina Siligardi, Magdalena Lassinantti Gualtieri, Eleonora Maretti
Nanomaterials. 2020; 10(3): 568
[Pubmed]  [Google Scholar] [DOI]
6 Nanopolymersomes as potential carriers for rifampicin pulmonary delivery
Marcela A. Moretton,Maximiliano Cagel,Ezequiel Bernabeu,Lorena Gonzalez,Diego A. Chiappetta
Colloids and Surfaces B: Biointerfaces. 2015; 136: 1017
[Pubmed]  [Google Scholar] [DOI]
7 Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
Eleonora Maretti,Tiziana Rossi,Moreno Bondi,Maria Antonietta Croce,Miriam Hanuskova,Eliana Leo,Francesca Sacchetti,Valentina Iannuccelli
International Journal of Pharmaceutics. 2014; 462(1-2): 74
[Pubmed]  [Google Scholar] [DOI]
8 The Influence of Feedstock and Process Variables on the Encapsulation of Drug Suspensions by Spray-Drying in Fast Drying Regime: The Case of Novel Antitubercular Drug-Palladium Complex Containing Polymeric Microparticles
Stefano Giovagnoli,Francesco Palazzo,Alessandro Di Michele,Aurelie Schoubben,Paolo Blasi,Maurizio Ricci
Journal of Pharmaceutical Sciences. 2014; 103(4): 1255
[Pubmed]  [Google Scholar] [DOI]
9 In Silico children and the glass mouse model: Clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis
Jeena, P.M., Bishai, W.R., Pasipanodya, J.G., Gumbo, T.
Antimicrobial Agents and Chemotherapy. 2011; 55(2): 539-545
[Pubmed]  [Google Scholar]
10 An oracle: Antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future
Pasipanodya, J., Gumbo, T.
Antimicrobial Agents and Chemotherapy. 2011; 55(1): 24-34
[Pubmed]  [Google Scholar]
11 Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid : Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents
Keith A. Rodvold, Liz Yoo, Jomy M. George
Clinical Pharmacokinetics. 2011; 50(11): 689
[HTML Full text]  [Google Scholar] [DOI]
12 New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability
Gumbo, T.
Antimicrobial Agents and Chemotherapy. 2010; 54(4): 1484-1491
[Pubmed]  [Google Scholar]
13 New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
Tawanda Gumbo
Antimicrobial Agents and Chemotherapy. 2010; 54(4): 1484
[Pubmed]  [Google Scholar] [DOI]


Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow